ArticlePharmacogenomics2019
Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y
Brittney H Davis, Chrisly Dillon, Anping Cai, Lance A Williams Iii, Salpy V Pamboukian, Nita A Limdi
Abstract readCase Reports
In one paragraphArticle in Pharmacogenomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Brittney H DavisDepartment of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA 35294.
Chrisly DillonDepartment of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA 35294.
Anping CaiDepartment of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA 35294.
Lance A Williams IiiDepartment of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA 35249.
Salpy V PamboukianDepartment of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA 35242.
Nita A LimdiDepartment of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA 35294.
Funding
Predictors of hemorrhage among patients on direct acting oral anticoagulantsR01HL092173 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIMDI, NITA A · 2008 to 2023
$10.4MUAB-HudsonAlpha Genomic Medicine Training ProgramT32HG008961 · NHGRI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Gregory Michael Cooper, Marguerite R Irvin · 2016 to 2026
$2.5MPatient Oriented Research in Personalized Antithrombotic TherapyK24HL133373 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIMDI, NITA A · 2016 to 2025
$1.2MNHGRI NIH HHS T32 HG008961NHLBI NIH HHS K24 HL133373NHLBI NIH HHS R01 HL092173
6 · The paper itselfAbstract
Indexed as
AdultBlood PlateletsClopidogrelCytochrome P-450 CYP2B6Cytochrome P-450 CYP2C19FemaleGenotypeHumansPlatelet AggregationPlatelet Aggregation InhibitorsPrasugrel HydrochlorideReceptors, Purinergic P2Y12Ventricular Dysfunction, LeftClopidogrelCYP2B6 protein, humanCYP2C19 protein, humanCytochrome P-450 CYP2B6Cytochrome P-450 CYP2C19P2RY12 protein, humanPlatelet Aggregation InhibitorsPrasugrel HydrochlorideReceptors, Purinergic P2Y12clopidogrelCYP2B6LVADP2Yprasugrelticagrelor
Identifiers
PMID31124414
PMCPMC6563016
What OpenQuestion holds
Textmetadata
Read underepoch 390